Research To Practice | Oncology Videos

Latest Episodes:

Gynecologic Oncology | Kathleen N Moore, MD, MS Feb 08, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology — Faculty Presentation 1: Ovarian Cancer — Dr Kathleen Moore

CME information and select publications

Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology Feb 08, 2023

Show notes

Featuring perspectives from Drs Michael Birrer and Kathleen Moore, including the following topics:

Gynecologic Oncology
- Introduction (0:00)

Ovarian Cancer
- PARP inhibitors as primary maintenance (8:11)
- PARP inhibitors for recurrent and metastatic disease (19:04)
- Antibody-drug conjugates: Mirvetuximab soravtansine; upifitamab rilsodotin (31:39)

Endometrial Cancer
- Immunotherapy for metastatic disease (43:49)
- Selinexor as maintenance therapy (51:33)
- Other novel agents (56:52)

Cervical Cancer
- Immunotherapy for metastatic disease and the antibody-drug conjugate tisotumab vedotin (1:01:00)

CME information and select publications

Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma (Companion Faculty Lecture) Feb 06, 2023

Show notes

Featuring a slide presentation and related discussion from Dr Gilles Salles, including the following topics:

Recent data with polatuzumab vedotin/bendamustine/rituximab for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) (0:00)
Available data from trials evaluating tafasitamab/lenalidomide, loncastuximab tesirine and selinexor for DLBCL (12:57)
Current and future roles of chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies and combination therapies for DLBCL (21:43)

CME information and select publications

Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma Feb 06, 2023

Show notes

Featuring an interview with Dr Gilles Salles, including the following topics:

Biology underlying B-cell lymphomas, role of Bruton tyrosine kinase (BTK) inhibitors in lymphomas and reason for cure in diffuse large B-cell lymphoma (DLBCL) versus indolent lymphomas (0:00)
Efficacy, tolerability and optimal sequencing of selinexor, polatuzumab vedotin/bendamustine/rituximab, tafasitamab/lenalidomide and loncastuximab tesirine for DLBCL (6:32)
Ongoing trials evaluating selinexor, tafasitamab/lenalidomide and loncastuximab tesirine for DLBCL (14:24)
Managing cytokine release syndrome associated with bispecific antibodies; eligibility considerations with bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy (18:02)
Case: A man in his late 60s diagnosed with DLBCL who has a history of ulcerative colitis and mitral valve repair (28:17)
Case: A woman in her early 80s with transformed DLBCL (35:14)
Case: A woman in her early 40s with DLBCL unresponsive to CAR T-cell therapy (38:05)

CME information and select publications

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting Feb 02, 2023

Show notes

Featuring perspectives from Dr Richard Stone, including the following topics:

Current and future trends in the care of patients with acute myeloid leukemia (AML) (0:00)
Management of AML with IDH1/2 and FLT3 mutations (17:28)
Advances in the treatment of high-risk AML (29:42)
Emerging data with novel therapies for AML with targetable mutations (36:53)
Hematopoietic stem cell transplantation as a treatment option for patients with relapsed or refractory AML (51:15)
Advances in the care of patients with myelodysplastic syndromes (56:19)

CME information and select publications

Multiple Myeloma | Ajay K Nooka, MD, MPH Feb 01, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma — Faculty Presentation 2: Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Other Novel Approaches for MM — Dr Ajay Nooka

CME information and select publications

Multiple Myeloma | Joseph Mikhael, MD, MEd Feb 01, 2023

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma — Faculty Presentation 1: Optimizing the Current Management of Multiple Myeloma (MM) — Dr Joseph Mikhael

CME information and select publications

Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma Feb 01, 2023

Show notes

Featuring perspectives from Drs Joseph Mikhael and Ajay Nooka, including the following topics:

Introduction (0:00)
Front-Line Treatment; Autologous Stem Cell Transplant (11:36)
Use of Anti-CD38 Antibodies (29:36)
CAR T-Cell Therapy (38:16)
Treatment with Bispecific Antibodies (48:59)
Other Treatments for Relapsed/Refractory Disease (56:07)

CME information and select publications

Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Management of ER-Positive Breast Cancer Jan 31, 2023

Show notes

Featuring perspectives from Drs Erica Mayer and Ruth O'Regan, including the following topics:

Pregnancy during adjuvant endocrine therapy; fertility issues (0:00)
Genomic biomarkers in the adjuvant setting (16:28)
CDK4/6 inhibitors in metastatic disease (31:58)
Adjuvant use of CDK4/6 inhibitors (47:42)
Novel agents in metastatic disease (1:14:26)

CME information and select publications

Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer (Companion Video Lecture) Jan 26, 2023

Show notes

Featuring a slide presentation and related discussion from Professor Giuseppe Curigliano, including the following topics:

Recent data with targeted therapies for patients with HER2-positive metastatic breast cancer (0:00)
Case: A woman in her early 40s with a new right breast tumor 10 years after adjuvant radiation and endocrine therapy (17:17)
Case: A woman in her mid 20s with a family history of breast cancer presenting with a lump in her left breast (26:34)

CME information and select publications